ARCHIVES

In Brief: Bruce Chamber Is DeVita’s Choice as Permanent Director Of DCT; Six New RCDAs Funded In FY 1982

This article is from The Cancer Letter archive.

Vol. 08 No. 24 | June 11, 1982

Download PDF Visit The Full Archive

Related Articles

FDA Requires Independent Confirmation of Disease Progression in Cooperative Group Trials; Seeks Documentation for Avastin in Breast Cancer.

September 15, 2006

Research: No Increase in Cancer Deaths Found at Three Mile Island

May 5, 2000

ASCO Annual Meeting: New Approaches For Treatment of Hematologic Malignancies

June 30, 2006

Proposed Deal Could Resolve Key Disputes At NSABP, Pitt

January 13, 1995

Tarceva-Induced Rash Strongly Associated With Longer Survival, Sponsor Finds

July 27, 2007

Arthur Upton Will Be New NCI Director; Colleagues Convinced He’ll Be strong Leader

June 10, 1977